Keywordsdietary intervention; metabolic syndrome; adiponectin; peroxisome proliferator activator receptor γ; dietary carbohydrate restriction; rats; lifestyle-related disease; nitric oxide (NO); nitrate; nitrite; insulin resistance; ischemia/reperfusion injury; chronic obstructive pulmonary disease (COPD); osteoporosis; cancer; metabolic syndrome; green tea; epigallocatechin gallate; EGCG; endothelial dysfunction; cardiovascular diseases; postprandial status; amino acid and biogenic amine profiles; insulin; highland barley; impaired fasting glucose; endotoxin; type 2 diabetes mellitus; Arab women; high fat meal; MTHFR C677T; MTHFR A1298C; MTR A2756G; MTRR A66G; folate deficiency; fatty acid analysis; fetal programming; metabolic disease; enterocytes; jejunum; glucose transport; SGLT1; GLUT2; Caco-2; hyperglycemia; hyperlipidemia; rutin; obesity; skeletal muscle; mitochondria; AMPK activity; Type 1 diabetes; autoimmunity; diet; gut microbiota; dysbiosis; Bacteroides; meal replacement; visceral fat; metabolic syndrome; lifestyle intervention; vanillic acid; insulin resistance; hyperinsulinemia; hyperglycemia; hyperlipidemia; naringin; NRTIs; metabolic complications; apoptosis; oxidative stress; 6,8-Diprenylgenistein (DPG); Cudrania tricuspidata; high-fat diet-induced obesity; lipid profile; AMPK; docosahexaenoic acid; feto-placental; lipids; ω-3 fatty acids; ω-6 fatty acids; triglycerides; selenium; selenoproteins; metabolic disease; trace element; branched-chain amino acids; leucine; isoleucine; valine; glucose metabolism; nutrient sensing; hypothalamus; liver; Allomyrina dichotoma larvae; diet-induced obesity; ER stress; hypothalamus; appetite; honey; diabetes mellitus; hyperglycemia; hyperlipidemia; dyslipidemia; lipid profile; alloxan; rats; vitamin B-12; oxidative stress; inflammation; vegetarian; diabetes; obesity; apple-derived pectin; gut microbiota; gut barrier function; metabolic endotoxemia; systematic review; advanced glycation end-products; diet; chronic kidney disease; diabetes; cardiovascular disease; inflammation; calcitriol; glucose homeostasis; HepG2; hypovitaminosis D; insulin secretion; lipid metabolism; Mediterranean diet; metabolic syndrome; meta-analysis; iodine; serum lipids; cholesterol; dyslipidemia; NHANES; metabolic disorders; type 2 diabetes (T2DM); cardiovascular diseases (CVD); gut microbiota; probiotics; prebiotics; metabolic programming; adipocyte precursor cells; dysfunctional adipose tissue; altered glucose tolerance; insulin resistance; pre-diabetes; metabolic syndrome; retroperitoneal adipose tissue; adipogenesis; SVF cells; precursor cell competency; high-fat diet; alternate-day; mitochondria; skeletal muscle; rat; intestinal microbiota; obesity; diabetes; metabolic syndrome; energy harvest; diet; absorption; bile acids; low-grade inflammation; SCFA; lysosome; cell death; metabolism; inflammasome; chili pepper; capsaicin; TRPV1; metabolic syndrome; obesity; hypertension; diabetes; bone; diet; glucose; growth; lean body mass; magnesium deficiency; obesity; rat; quercetin; phytochemicals; enolase 2; ENO2; angiopoietin-like 4; ANGPTL4; plasminogen activator inhibitor-1; PAI-1; SERPINE1; phosopho-fructokinase; PFKP; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4; PFKFB4; complement factor D; adipsin; CFD; fibronectin type III domain-containing 5; irisin; FNDC5; interleukin-1β; IL1B; insulin resistance; EPA; DHA; n-3 PUFA; mitochondria; muscle; diet; Mediterranean; DASH; cardiovascular disease; coronary artery disease; heart failure; hypertension; caloric restriction; dietary intervention; endothelial dysfunction; cardiovascular disease; obesity; fermented red ginseng; metabolic syndrome; obesity; hyperlipidemia; hypertension; aloe vera; prediabetes; randomized controlled trials; meta-analysis; dietary histidine; overweight/obesity; insulin resistance; inflammation; oxidative stress; n/a
